Pharmacokinetics of inhaled colistimethate sodium (CMS) in mechanically ventilated critically ill patients

High Prevalence of Multidrug-Resistant Nonfermenters in Hospital-acquired Pneumonia in Asia

(2011) Doo Ryeon Chung et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

A retrospective observational study on the efficacy of colistin by inhalation as compared to parenteral administration for the treatment of nosocomial pneumonia associated with multidrug-resistant Pseudomonas aeruginosa

(2011) Reinout Naesens et al.   BMC INFECTIOUS DISEASES

Colistin Penetration in the Alveolar Lining Fluid of Critically Ill Patients Treated With IV Colistimethate Sodium

(2011) Nikolaos Markou et al.   CHEST

Aerosol Therapy with Colistin Methanesulfonate: a Biopharmaceutical Issue Illustrated in Rats

(2010) S. Marchand et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Steady-State Pharmacokinetics and BAL Concentration of Colistin in Critically Ill Patients After IV Colistin Methanesulfonate Administration

(2010) Roberto Imberti et al.   CHEST

Aerosolized plus Intravenous Colistin versus Intravenous Colistin Alone for the Treatment of Ventilator‐Associated Pneumonia: A Matched Case‐Control Study

(2010) Diamantis P. Kofteridis et al.   CLINICAL INFECTIOUS DISEASES

Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa

(2010) Qin Lu et al.   INTENSIVE CARE MEDICINE

Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria

(2010) P. Rattanaumpawan et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models

(2010) R. V. Dudhani et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria

(2009) D. Plachouras et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study

(2009) I.P. Korbila et al.   CLINICAL MICROBIOLOGY AND INFECTION

Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa

(2009) N. Aoki et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Predictors of 30-Day Mortality and Hospital Costs in Patients With Ventilator-Associated Pneumonia Attributed to Potentially Antibiotic-Resistant Gram-Negative Bacteria

(2008) Katherine E. Kollef et al.   CHEST

Ventilator-Associated Tracheobronchitis

(2008) Donald E. Craven et al.   CHEST

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES